No Data
Tectonic Started at Outperform by Raymond James, TX45 Cited
Raymond James Initiates Tectonic Therapeutic(TECX.US) With Buy Rating, Announces Target Price $65
Tectonic Therapeutic Inc. Faces Challenges With Australian Subsidiary Amid Regulatory and Operational Risks
Tectonic Therapeutic | 10-Q: Q3 2024 Earnings Report
Insiders Continue to Buy Tectonic Therapeutic, Inc. (NASDAQ:TECX) and Now Own 41% Shares
Wells Fargo Maintains Tectonic Therapeutic(TECX.US) With Buy Rating, Maintains Target Price $79
No Data
No Data